1
Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.
Condition(s):Cerebrovascular AccidentLast Updated:January 4, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.